Cargando…
Intravitreal use of bone marrow mononuclear fraction containing CD34(+) stem cells in patients with atrophic age-related macular degeneration
PURPOSE: To evaluate the therapeutic potential and safety of intravitreal injections of bone marrow mononuclear fraction (BMMF) containing CD34(+) cells in patients with atrophic age-related macular degeneration (AMD). METHODS: Ten patients with atrophic AMD and best-corrected visual acuity (BCVA) i...
Autores principales: | Cotrim, Carina Costa, Toscano, Luiza, Messias, André, Jorge, Rodrigo, Siqueira, Rubens Camargo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449098/ https://www.ncbi.nlm.nih.gov/pubmed/28579742 http://dx.doi.org/10.2147/OPTH.S133502 |
Ejemplares similares
-
Intravitreal Use of a Bone Marrow Mononuclear Fraction (BMMF) Containing CD34+ Cells in Patients with Stargardt Type Macular Dystrophy
por: Cotrim, Carina Costa, et al.
Publicado: (2020) -
Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study
por: Gonzalez, Victor H., et al.
Publicado: (2021) -
Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
por: Chan, Clement K., et al.
Publicado: (2023) -
One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
por: Hirakata, Toshiaki, et al.
Publicado: (2016) -
Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)
por: Siqueira, Rubens C, et al.
Publicado: (2015)